Apollon Wealth Management, LLC Bria Cell Therapeutics Corp. Transaction History

Apollon Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$3.0 - $8.31 $6,000 - $16,620	2,000 Added 12.58%	17,900 $101,000
Q2 2022 Aug 11, 2022	BUY	$4.28 - $11.9 $8,560 - $23,800	2,000 Added 14.39%	15,900 $92,000
Q1 2022 May 16, 2022	SELL	$5.91 - $10.14 $53,190 - $91,260	-9,000 Reduced 39.3%	13,900 $141,000
Q4 2021 Feb 14, 2022	BUY	$7.1 - $10.61 $24,850 - $37,135	3,500 Added 18.04%	22,900 $190,000
Q3 2021 Nov 15, 2021	BUY	$4.4 - $9.28 $85,360 - $180,032	19,400 New	19,400 $157,000

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $16M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Apollon Wealth Management, LLC with notifications on news.